Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artekin versus artesunate + mefloquine for uncomplicated Plasmodium falciparum malaria
ISRCTN81306618Phase 3Completed
- Sponsor
- Leadiant Biosciences
- Start
- Jan 2000
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial in Malaria comparing Artekin with Artesunate + mefloquine (2 arms). Primary endpoint: Day 63 PCR-corrected cure rate. Started Jan 2000; status: completed.
02
Drugs
dihydroartemisinin + piperaquineartesunatemefloquine
03
Conditions
Malaria
Beyond the preview
Go deeper on ISRCTN81306618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN81306618.